Found: 3
Select item for more details and to access through your institution.
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.
- Published in:
- Journal of Bone & Mineral Research, 2019, v. 34, n. 3, p. 419, doi. 10.1002/jbmr.3622
- By:
- Publication type:
- Article
Human immunodeficiency virus and renal transplantation.
- Published in:
- Kidney International, 2009, v. 76, n. 8, p. 907, doi. 10.1038/ki.2009.184
- By:
- Publication type:
- Article
Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
- Published in:
- Archives of Osteoporosis, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1007/s11657-019-0608-z
- By:
- Publication type:
- Article